Apimeds Pharmaceuticals Files 2024 10-K Report
Ticker: APUS · Form: 10-K · Filed: Apr 15, 2025 · CIK: 1894525
| Field | Detail |
|---|---|
| Company | Apimeds Pharmaceuticals Us, INC. (APUS) |
| Form Type | 10-K |
| Filed Date | Apr 15, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, annual-report, pharmaceuticals
TL;DR
Apimeds Pharma filed its 2024 10-K. Check financials.
AI Summary
Apimeds Pharmaceuticals US, Inc. filed its annual report on Form 10-K for the fiscal year ended December 31, 2024. The company, incorporated in Delaware with its principal executive offices in Hopewell, NJ, operates in the pharmaceutical preparations industry. The filing was made on April 15, 2025, under SEC file number 001-42545.
Why It Matters
This 10-K filing provides a comprehensive overview of Apimeds Pharmaceuticals' financial performance and business operations for the fiscal year 2024, crucial for investors and stakeholders to assess the company's health and future prospects.
Risk Assessment
Risk Level: low — This is a standard annual filing and does not inherently indicate new risks.
Key Numbers
- 2024 — Fiscal Year End (The period covered by the annual report.)
- 001-42545 — SEC File Number (Unique identifier for the company's filings.)
- 2834 — SIC Code (Industry classification for Pharmaceutical Preparations.)
Key Players & Entities
- Apimeds Pharmaceuticals US, Inc. (company) — Registrant
- 2024 (date) — Fiscal year end
- April 15, 2025 (date) — Filing date
- 001-42545 (dollar_amount) — SEC File Number
- Delaware (company) — State of incorporation
- Hopewell, NJ (company) — Principal executive offices
FAQ
What is the primary business of Apimeds Pharmaceuticals US, Inc.?
Apimeds Pharmaceuticals US, Inc. operates in the Pharmaceutical Preparations industry, as indicated by its SIC code 2834.
When was the 10-K report filed?
The 10-K report was filed on April 15, 2025.
What fiscal year does this 10-K report cover?
This 10-K report covers the fiscal year ended December 31, 2024.
Where are Apimeds Pharmaceuticals US, Inc.'s principal executive offices located?
The principal executive offices of Apimeds Pharmaceuticals US, Inc. are located at 2 East Broad Street, 2nd Floor, Hopewell, NJ 08425.
What is the company's SEC file number?
The company's SEC file number is 001-42545.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on April 15, 2025 regarding Apimeds Pharmaceuticals US, Inc. (APUS).